• Accendra Health posted a GAAP net loss from continuing operations of USD 6.47 million, or USD 0.08 per share, as net revenue fell to USD 627.8 million.
• Adjusted EBITDA dropped to USD 58.4 million, while free cash flow swung to an outflow of USD 2 million.
• Cash and cash equivalents rose to USD 336.88 million, while total debt increased to USD 2.1 billion, leaving net debt at USD 1.77 billion.
• Accendra announced more than USD 1.5 billion balance sheet optimization transaction with commitments from existing creditors, aiming to pay off 2027 maturities, extend revolving credit facility maturities, reduce total leverage.
• Edward A. Pesicka said results aligned with expectations as Accendra continues transition into a pure-play home-based care company, while affirming prior full-year 2026 guidance for net revenue and adjusted EBITDA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accendra Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260511344561) on May 11, 2026, and is solely responsible for the information contained therein.